BRIEF published on 10/29/2025 at 09:50, 6 months 3 days ago Evotec SE to Release Q3 2025 Financial Results on November 5th Financial Results Conference Call Life Sciences Evotec SE 2025 Performance
PRESS RELEASE published on 10/29/2025 at 09:45, 6 months 3 days ago Evotec SE to announce results for the first nine months 2025 on 05 November 2025 Evotec SE to announce results for the first nine months 2025 on 05 November 2025. The Company will hold a conference call in English to discuss the interim statement Conference Call Financial Report Evotec SE Results Interim Statement
BRIEF published on 10/27/2025 at 07:35, 6 months 5 days ago Evotec Advances in Neuroscience Partnership with Bristol Myers Squibb Partnership Neuroscience Evotec Bristol Myers Squibb Neurodegenerative
PRESS RELEASE published on 10/27/2025 at 07:30, 6 months 5 days ago Evotec announces progress in preclinical neuroscience partnership with Bristol Myers Squibb Evotec SE announces US$ 25 m payment from Bristol Myers Squibb for progress in preclinical neuroscience partnership, advancing research on neurodegenerative diseases Partnership Evotec SE Neurodegenerative Diseases Bristol Myers Squibb Research Progress
BRIEF published on 08/13/2025 at 07:05, 8 months 19 days ago Evotec SE Reports H1 2025 Results Highlighting Strategic Progress Financial Performance Evotec SE Strategic Growth Biologics Development H1 2025 Results
PRESS RELEASE published on 08/13/2025 at 07:00, 8 months 19 days ago Evotec SE reports H1 2025 results: Strong progress on strategy execution Evotec SE reports strong progress on strategy execution with H1 2025 results, showcasing sustainable profitable growth and key collaborations with BMS and Sandoz Evotec SE Growth Collaborations Strategy Execution H1 2025 Results
BRIEF published on 08/06/2025 at 09:57, 8 months 26 days ago Evotec SE to Release First Half-Year Results 2025 Conference Call Drug Discovery Life Sciences Evotec SE Half-year Results
PRESS RELEASE published on 08/06/2025 at 09:52, 8 months 26 days ago Evotec SE to announce first half-year results 2025 on 13 August 2025 Evotec SE to announce first half-year results for 2025 on 13 August 2025 with a conference call to discuss performance. Company focuses on drug discovery and development Conference Call Drug Discovery Evotec SE Half-year Results AI-driven Innovation
BRIEF published on 07/30/2025 at 07:21, 9 months 2 days ago Evotec and Sandoz Advance Partnership with Potential Toulouse Site Sale Strategic Partnership Evotec SE Biologics Manufacturing Sandoz AG Asset-Lighter Model
BRIEF published on 07/30/2025 at 07:19, 9 months 2 days ago Evotec SE and Sandoz AG to Potentially Sell Just – Evotec Biologics Toulouse Site Evotec SE Transaction Terms Sandoz AG Biologics Sale Toulouse Site
Published on 05/02/2026 at 01:30, 18 minutes ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 58 minutes ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 hour 48 minutes ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 hour 48 minutes ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 3 hours 18 minutes ago Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 19:23, 6 hours 24 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 8 hours 2 minutes ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 8 hours 26 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 04/30/2026 at 20:00, 1 day 5 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 6 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 6 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 7 hours ago Minutes of the Combined General Meeting held on April 30, 2026
